Annual accounts receivable:
$716.76M+$10.97M(+1.55%)Summary
- As of today (May 21, 2025), JAZZ annual accounts receivable is $716.76 million, with the most recent change of +$10.97 million (+1.55%) on December 31, 2024.
- During the last 3 years, JAZZ annual accounts receivable has risen by +$153.41 million (+27.23%).
- JAZZ annual accounts receivable is now at all-time high.
Performance
JAZZ Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$652.99M-$63.77M(-8.90%)Summary
- As of today (May 21, 2025), JAZZ quarterly accounts receivable is $652.99 million, with the most recent change of -$63.77 million (-8.90%) on March 1, 2025.
- Over the past year, JAZZ quarterly accounts receivable has dropped by -$54.10 million (-7.65%).
- JAZZ quarterly accounts receivable is now -9.76% below its all-time high of $723.64 million, reached on September 30, 2024.
Performance
JAZZ Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
JAZZ Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1.6% | -7.7% |
| 3 y3 years | +27.2% | +14.1% |
| 5 y5 years | +101.3% | +105.8% |
JAZZ Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +27.2% | -9.8% | +14.1% |
| 5 y | 5-year | at high | +101.3% | -9.8% | +105.8% |
| alltime | all time | at high | >+9999.0% | -9.8% | >+9999.0% |
JAZZ Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $652.99M(-8.9%) |
| Dec 2024 | $716.76M(+1.6%) | $716.76M(-0.9%) |
| Sep 2024 | - | $723.64M(+3.7%) |
| Jun 2024 | - | $698.04M(-1.3%) |
| Mar 2024 | - | $707.10M(+0.2%) |
| Dec 2023 | $705.79M(+8.3%) | $705.79M(+12.4%) |
| Sep 2023 | - | $627.84M(+2.9%) |
| Jun 2023 | - | $610.39M(-2.2%) |
| Mar 2023 | - | $623.94M(-4.2%) |
| Dec 2022 | $651.49M(+15.6%) | $651.49M(+8.4%) |
| Sep 2022 | - | $601.18M(+1.2%) |
| Jun 2022 | - | $594.03M(+3.8%) |
| Mar 2022 | - | $572.39M(+1.6%) |
| Dec 2021 | $563.36M(+42.1%) | $563.36M(+12.9%) |
| Sep 2021 | - | $499.02M(-1.5%) |
| Jun 2021 | - | $506.66M(+22.4%) |
| Mar 2021 | - | $413.98M(+4.4%) |
| Dec 2020 | $396.49M(+11.4%) | $396.49M(+9.6%) |
| Sep 2020 | - | $361.66M(+2.8%) |
| Jun 2020 | - | $351.92M(+10.9%) |
| Mar 2020 | - | $317.30M(-10.9%) |
| Dec 2019 | $355.99M(+34.9%) | $355.99M(+33.3%) |
| Sep 2019 | - | $267.03M(-14.2%) |
| Jun 2019 | - | $311.25M(-2.9%) |
| Mar 2019 | - | $320.49M(+21.5%) |
| Dec 2018 | $263.84M(+17.7%) | $263.84M(-5.6%) |
| Sep 2018 | - | $279.44M(+0.4%) |
| Jun 2018 | - | $278.44M(-1.1%) |
| Mar 2018 | - | $281.42M(+25.6%) |
| Dec 2017 | $224.13M(-4.3%) | $224.13M(-13.3%) |
| Sep 2017 | - | $258.62M(+8.3%) |
| Jun 2017 | - | $238.75M(-1.8%) |
| Mar 2017 | - | $243.03M(+3.8%) |
| Dec 2016 | $234.24M(+11.7%) | $234.24M(-1.6%) |
| Sep 2016 | - | $238.07M(+2.7%) |
| Jun 2016 | - | $231.84M(+3.6%) |
| Mar 2016 | - | $223.80M(+6.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2015 | $209.69M(+12.5%) | $209.69M(+7.1%) |
| Sep 2015 | - | $195.82M(+1.1%) |
| Jun 2015 | - | $193.65M(+2.1%) |
| Mar 2015 | - | $189.68M(+1.8%) |
| Dec 2014 | $186.37M(+49.3%) | $186.37M(-0.7%) |
| Sep 2014 | - | $187.60M(+16.7%) |
| Jun 2014 | - | $160.78M(+3.7%) |
| Mar 2014 | - | $154.99M(+24.2%) |
| Dec 2013 | $124.81M(+65.3%) | $124.81M(+10.2%) |
| Sep 2013 | - | $113.27M(-0.7%) |
| Jun 2013 | - | $114.08M(+21.6%) |
| Mar 2013 | - | $93.83M(+24.3%) |
| Dec 2012 | $75.48M(+119.6%) | $75.48M(-14.5%) |
| Sep 2012 | - | $88.30M(+13.0%) |
| Jun 2012 | - | $78.13M(+39.2%) |
| Mar 2012 | - | $56.14M(+63.3%) |
| Dec 2011 | $34.37M(+55.7%) | $34.37M(+9.4%) |
| Sep 2011 | - | $31.43M(+25.7%) |
| Jun 2011 | - | $25.00M(+16.9%) |
| Mar 2011 | - | $21.38M(-3.2%) |
| Dec 2010 | $22.08M(+79.3%) | $22.08M(+56.7%) |
| Jun 2010 | - | $14.10M(+17.9%) |
| Mar 2010 | - | $11.96M(-2.9%) |
| Dec 2009 | $12.31M(+85.4%) | $12.31M(+33.8%) |
| Sep 2009 | - | $9.20M(+0.1%) |
| Jun 2009 | - | $9.20M(+31.2%) |
| Mar 2009 | - | $7.01M(+5.6%) |
| Dec 2008 | $6.64M(+23.3%) | $6.64M(-0.6%) |
| Sep 2008 | - | $6.69M(+28.1%) |
| Jun 2008 | - | $5.22M(-1.7%) |
| Mar 2008 | - | $5.31M(-1.5%) |
| Dec 2007 | $5.39M(+0.2%) | $5.39M(-17.9%) |
| Sep 2007 | - | $6.57M(+1.6%) |
| Jun 2007 | - | $6.46M(+4.8%) |
| Mar 2007 | - | $6.17M(+14.6%) |
| Dec 2006 | $5.38M(+49.6%) | $5.38M(+49.6%) |
| Dec 2005 | $3.60M | $3.60M |
FAQ
- What is Jazz Pharmaceuticals annual accounts receivable?
- What is the all time high annual accounts receivable for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals annual accounts receivable year-on-year change?
- What is Jazz Pharmaceuticals quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals quarterly accounts receivable year-on-year change?
What is Jazz Pharmaceuticals annual accounts receivable?
The current annual accounts receivable of JAZZ is $716.76M
What is the all time high annual accounts receivable for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high annual accounts receivable is $716.76M
What is Jazz Pharmaceuticals annual accounts receivable year-on-year change?
Over the past year, JAZZ annual accounts receivable has changed by +$10.97M (+1.55%)
What is Jazz Pharmaceuticals quarterly accounts receivable?
The current quarterly accounts receivable of JAZZ is $652.99M
What is the all time high quarterly accounts receivable for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high quarterly accounts receivable is $723.64M
What is Jazz Pharmaceuticals quarterly accounts receivable year-on-year change?
Over the past year, JAZZ quarterly accounts receivable has changed by -$54.10M (-7.65%)